Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Warfarin Interaction With Hepatic Cytochrome P-450 Enzyme-Inducing Anticonvulsants.

Clark NP, Hoang K, Delate T, Horn JR, Witt DM.

Clin Appl Thromb Hemost. 2018 Jan;24(1):172-178. doi: 10.1177/1076029616687849. Epub 2017 Jan 25.

PMID:
28118749
2.

Using Nonexperts for Annotating Pharmacokinetic Drug-Drug Interaction Mentions in Product Labeling: A Feasibility Study.

Hochheiser H, Ning Y, Hernandez A, Horn JR, Jacobson R, Boyce RD.

JMIR Res Protoc. 2016 Apr 11;5(2):e40. doi: 10.2196/resprot.5028.

3.

Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3A4 and P-glycoprotein substrates.

Chan LN, Lin YS, Tay-Sontheimer JC, Trawick D, Oelschlager BK, Flum DR, Patton KK, Shen DD, Horn JR.

Pharmacotherapy. 2015 Apr;35(4):361-9. doi: 10.1002/phar.1560. Epub 2015 Mar 10.

4.

Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.

Scheife RT, Hines LE, Boyce RD, Chung SP, Momper JD, Sommer CD, Abernethy DR, Horn JR, Sklar SJ, Wong SK, Jones G, Brown ML, Grizzle AJ, Comes S, Wilkins TL, Borst C, Wittie MA, Malone DC.

Drug Saf. 2015 Feb;38(2):197-206. doi: 10.1007/s40264-014-0262-8.

5.

Clinical decision support for drug-drug interactions: improvement needed.

Horn JR, Gumpper KF, Hardy JC, McDonnell PJ, Phansalkar S, Reilly C.

Am J Health Syst Pharm. 2013 May 15;70(10):905-9. doi: 10.2146/ajhp120405. No abstract available.

PMID:
23640353
6.

Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness.

Boyce RD, Horn JR, Hassanzadeh O, Waard Ad, Schneider J, Luciano JS, Rastegar-Mojarad M, Liakata M.

J Biomed Semantics. 2013 Jan 26;4(1):5. doi: 10.1186/2041-1480-4-5.

7.

Inhibitory metabolic drug interactions with newer psychotropic drugs: inclusion in package inserts and influences of concurrence in drug interaction screening software.

Boyce RD, Collins C, Clayton M, Kloke J, Horn JR.

Ann Pharmacother. 2012 Oct;46(10):1287-98. doi: 10.1345/aph.1R150. Epub 2012 Oct 2.

PMID:
23032655
8.

OTC polyethylene glycol 3350 and pharmacists' role in managing constipation.

Horn JR, Mantione MM, Johanson JF.

J Am Pharm Assoc (2003). 2012 May-Jun;52(3):372-80. doi: 10.1331/JAPhA.2012.10161. Review.

PMID:
22618979
9.

Careful scrutiny of the evidence for drug-drug interactions in clinical decision support systems is necessary.

Horn JR, Hansten PD.

J Manag Care Pharm. 2011 Nov;17(9):713. No abstract available.

10.

Comment: evaluation of contraindicated drug-drug interaction alerts in a hospital setting.

Horn JR, Hansten PD.

Ann Pharmacother. 2011 Jun;45(6):826; author reply 826-7. doi: 10.1345/aph.1P533a. Epub 2011 Jun 13. No abstract available.

PMID:
21672901
11.

Hard-stops for drug interactions.

Horn JR.

Arch Intern Med. 2011 Apr 11;171(7):706; author reply 706-7. doi: 10.1001/archinternmed.2011.109. No abstract available.

PMID:
21482852
12.

Customizing clinical decision support to prevent excessive drug-drug interaction alerts.

Horn JR, Hansten PD, Osborn JD, Wareham P, Somani S.

Am J Health Syst Pharm. 2011 Apr 15;68(8):662-4. doi: 10.2146/ajhp100465. No abstract available.

PMID:
21460171
13.

The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers.

Wright AJ, Gomes T, Mamdani MM, Horn JR, Juurlink DN.

CMAJ. 2011 Feb 22;183(3):303-7. doi: 10.1503/cmaj.100702. Epub 2011 Jan 17.

14.

Analysis of purported erythromycin-warfarin interaction.

Horn JR.

Am J Health Syst Pharm. 2010 Jun 15;67(12):966; author reply 966, 968. doi: 10.2146/ajhp100015. No abstract available.

PMID:
20516463
15.

What do medical records tell us about potentially harmful co-prescribing?

Elston Lafata J, Simpkins J, Kaatz S, Horn JR, Raebel MA, Schultz L, Smith DH, Yood MU.

Jt Comm J Qual Patient Saf. 2007 Jul;33(7):395-400.

PMID:
17711141
16.

Proposal for a new tool to evaluate drug interaction cases.

Horn JR, Hansten PD, Chan LN.

Ann Pharmacother. 2007 Apr;41(4):674-80. Epub 2007 Mar 27.

PMID:
17389673
17.

Potential drug-drug interactions in the outpatient setting.

Lafata JE, Schultz L, Simpkins J, Chan KA, Horn JR, Kaatz S, Long C, Platt R, Raebel MA, Smith DH, Xi H, Yood MU.

Med Care. 2006 Jun;44(6):534-41.

PMID:
16708002

Supplemental Content

Loading ...
Support Center